GO:0017101 aminoacyl-tRNA synthetase multienzyme complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0017101 describes a conserved multienzyme complex of aminoacyl-tRNA synthetases found in all multicellular eukaryotes.
• The complex contains eight aminoacyl-tRNA synthetases (ArgRS, AspRS, GluProRS, GlnRS, IleRS, LeuRS, LysRS, MetRS) plus three non-synthetase proteins (p43, p38, p18).
• Several subunits are dimers, giving a total polypeptide count of at least fifteen.
• All enzymes in the complex catalyze amino acid attachment to the 2'- or 3'-hydroxyl of tRNA's 3'-terminal adenosine, but use different substrates.
• The complex enhances tRNA aminoacylation efficiency and is implicated in cancer and other diseases.
• CRISPR knockout, point mutation, knock-in, and overexpression models are key tools to dissect subunit functions and disease links.
Description
The aminoacyl-tRNA synthetase multienzyme complex (GO:0017101) is a large cellular assembly that brings together multiple aminoacyl-tRNA synthetases and auxiliary proteins to ensure efficient protein synthesis. This complex is a hallmark of multicellular eukaryotes and has been studied from Drosophila to mammals. Its components catalyze the covalent attachment of amino acids to their cognate tRNAs, a fundamental step in translation. Beyond translation, the complex has been linked to cancer progression and other human diseases, making it a subject of intense research. Understanding its structure, assembly, and regulation is essential for uncovering new therapeutic targets.
aminoacyl-tRNA synthetase multienzyme complex At A Glance
| GO ID | GO:0017101 |
|---|---|
| GO term | aminoacyl-tRNA synthetase multienzyme complex |
| Ontology | cellular_component |
| Synonym | aminoacyl-tRNA synthetase complex, multisynthetase complex |
| Major function | Covalent attachment of amino acids to tRNA for protein synthesis |
| Subunits | Eight aminoacyl-tRNA synthetases (ArgRS, AspRS, GluProRS, GlnRS, IleRS, LeuRS, LysRS, MetRS) and three non-synthetase proteins (p43, p38, p18) |
| Polypeptide count | At least fifteen due to dimerization of some subunits |
| Conservation | Ubiquitous from Drosophila to mammals |
What Is GO:0017101?
GO:0017101 defines a multienzyme complex found in all multicellular eukaryotes that is composed of eight proteins with aminoacyl-tRNA synthetase activities (ArgRS, AspRS, GluProRS, GlnRS, IleRS, LeuRS, LysRS, MetRS) and three non-synthetase proteins (p43, p38, p18) with diverse functions. Several subunits are known dimers, so the total polypeptide count is at least fifteen. All enzymes in this assembly catalyze the same reaction: the covalent attachment of an amino acid to either the 2'- or 3'-hydroxyl of the 3'-terminal adenosine of tRNA, but using different substrates.
Why Is aminoacyl-tRNA synthetase multienzyme complex Important in Cell Biology?
The aminoacyl-tRNA synthetase multienzyme complex is crucial for efficient and accurate protein synthesis, as it coordinates multiple aminoacylation reactions within a single assembly. Its dysfunction has been linked to cancer, where altered expression of its components can drive tumorigenesis. Moreover, the complex is a target for understanding evolutionary adaptations in eukaryotes and for developing novel therapeutics.
• Ensures efficient tRNA aminoacylation for translation.
• Coordinates multiple synthetases to enhance substrate channeling.
• Implicated in cancer development and progression.
• Provides insights into eukaryotic evolution.
• Serves as a model for studying multienzyme complex assembly.
• Potential target for antimicrobial and anticancer drugs.
• Links translation to signaling pathways and stress responses.
• Involved in neurological and developmental disorders.
• Facilitates study of non-canonical functions of synthetases.
• Enables high-throughput screening for modulators of protein synthesis.
What Happens During aminoacyl-tRNA synthetase multienzyme complex?
Assembly of the Multienzyme Complex
In simple terms: The complex is built from many protein pieces that come together.
The aminoacyl-tRNA synthetase multienzyme complex assembles from eight aminoacyl-tRNA synthetases and three auxiliary proteins (p43, p38, p18). Several subunits form dimers, resulting in at least fifteen polypeptides. Assembly is mediated by specific protein-protein interactions, as shown for the yeast Arc1p complex. This assembly is conserved from Drosophila to mammals.
tRNA Aminoacylation Reaction
In simple terms: Each enzyme attaches a specific amino acid to its matching tRNA.
Within the complex, each synthetase catalyzes the covalent attachment of its cognate amino acid to the 2'- or 3'-hydroxyl of the 3'-terminal adenosine of tRNA. This reaction is essential for translating the genetic code into proteins. The complex enhances the efficiency of this process compared to individual enzymes.
Substrate Channeling and Efficiency
In simple terms: The complex helps move molecules between enzymes more efficiently.
The multienzyme complex facilitates substrate channeling, allowing tRNAs and amino acids to be passed directly between synthetases. This increases the overall rate of aminoacylation and reduces the release of intermediates. Such coordination is particularly important in rapidly dividing cells.
Non-canonical Functions
In simple terms: Some parts of the complex have jobs beyond making proteins.
Several subunits, such as GluProRS, have additional functions in signaling and immune responses. The non-synthetase proteins p43, p38, and p18 also participate in diverse cellular processes. These non-canonical roles link the complex to cancer and other diseases.
Key Genes Involved in GO:0017101 aminoacyl-tRNA synthetase multienzyme complex
The following genes encode the core components of the aminoacyl-tRNA synthetase multienzyme complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RARS | Arginyl-tRNA synthetase | Component of the complex; potential cancer target |
| DARS | Aspartyl-tRNA synthetase | Component; mutations linked to disease |
| EPRS | Glutamyl-prolyl-tRNA synthetase | Bifunctional enzyme; non-canonical roles |
| QARS | Glutaminyl-tRNA synthetase | Component; involved in translation |
| IARS | Isoleucyl-tRNA synthetase | Component; potential disease associations |
| LARS | Leucyl-tRNA synthetase | Component; regulates mTOR signaling |
| KARS | Lysyl-tRNA synthetase | Component; mutations cause neuropathy |
| MARS | Methionyl-tRNA synthetase | Component; linked to cancer |
| AIMP1 | p43 auxiliary protein | Non-synthetase subunit; cytokine-like functions |
| AIMP2 | p38 auxiliary protein | Non-synthetase subunit; tumor suppressor |
| AIMP3 | p18 auxiliary protein | Non-synthetase subunit; involved in DNA repair |
| ARC1 | Yeast auxiliary protein | Assembly factor in yeast |
| KARS1 | Lysyl-tRNA synthetase 1 | Dimerization and complex assembly |
| EPRS1 | Glutamyl-prolyl-tRNA synthetase 1 | Interferon response |
| MARS1 | Methionyl-tRNA synthetase 1 | Angiogenesis regulation |
| AIMP2 | p38 | Regulates complex stability |
| AIMP3 | p18 | Stress response |
How Is aminoacyl-tRNA synthetase multienzyme complex Regulated?
The aminoacyl-tRNA synthetase multienzyme complex is regulated at multiple levels. Its assembly is controlled by protein-protein interactions and post-translational modifications. The complex is also regulated by signaling pathways such as mTOR, which senses amino acid availability and controls protein synthesis. Additionally, the expression of individual subunits can be modulated in response to cellular stress and disease states.
aminoacyl-tRNA synthetase multienzyme complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KARS | Charcot-Marie-Tooth neuropathy | Knock-in mouse with patient mutation |
| AIMP2 | Cancer (lung, breast) | Knockout mouse and cancer cell lines |
| EPRS | Cancer and immune disorders | Overexpression and knockout models |
| MARS | Angiogenesis and cancer | Conditional knockout in endothelial cells |
| LARS | mTOR signaling and cancer | Point mutation knock-in |
Cancer
Dysregulation of aminoacyl-tRNA synthetase multienzyme complex components is frequently observed in cancers. For example, overexpression of AIMP2 and EPRS has been linked to tumor progression. The complex influences translation and signaling pathways that promote cell proliferation.
Neurodegeneration
Mutations in genes encoding complex subunits, such as KARS, are associated with Charcot-Marie-Tooth neuropathy. These mutations can impair tRNA aminoacylation and lead to neuronal dysfunction.
Infectious Diseases
In trypanosomes, a multiple aminoacyl-tRNA synthetase complex enhances tRNA-aminoacylation and is essential for parasite viability. This complex is a potential target for antiparasitic drugs.
From aminoacyl-tRNA synthetase multienzyme complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of KARS in neuropathy? | Knock-in mouse with KARS mutation |
| How does AIMP2 loss affect tumor growth? | AIMP2 knockout mouse and xenografts |
| Does EPRS have non-canonical functions? | EPRS knockout and overexpression cell lines |
| How is the complex assembled? | Tagged knock-in of subunits for affinity purification |
| What is the impact of LARS on mTOR? | Point mutation knock-in of LARS |
| Can the complex be targeted in parasites? | Trypanosome knockout models |
How to Study the aminoacyl-tRNA synthetase multienzyme complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| AP-MS | Protein interactions and complex composition | Identifying subunits and assembly factors |
| Ribo-seq | Translation efficiency and ribosome occupancy | Global effects of complex perturbation |
| RNA-seq | Gene expression changes | Knockout/overexpression studies |
| Fluorescence microscopy | Subcellular localization | Visualizing complex dynamics |
| Aminoacylation assay | Enzymatic activity | Testing mutations and inhibitors |
| CRISPR screening | Gene essentiality and synthetic lethality | Identifying dependencies |
| Co-immunoprecipitation | Physical interactions | Validating subunit associations |
Proteomics and Affinity Purification
Affinity purification coupled with mass spectrometry (AP-MS) is used to isolate the multienzyme complex and identify its components and interactors. This method reveals subunit stoichiometry and post-translational modifications.
Ribo-seq and RNA-seq
Ribo-seq measures translation efficiency and can reveal how complex components affect global protein synthesis. RNA-seq profiles gene expression changes upon knockout or overexpression of subunits.
Imaging and Localization
Fluorescence microscopy with tagged subunits visualizes the subcellular localization and dynamics of the complex. This helps determine whether the complex is cytoplasmic or nuclear.
Biochemical Assays
In vitro aminoacylation assays measure the catalytic activity of individual synthetases and the intact complex. These assays are used to test the impact of mutations and inhibitors.
How CRISPR Can Be Used to Study GO:0017101 aminoacyl-tRNA synthetase multienzyme complex
Knockout
CRISPR knockout of individual subunits (e.g., AIMP2, EPRS) can disrupt complex assembly and function, revealing their roles in translation and disease. Knockout models are used to study loss-of-function phenotypes in cancer and neurodegeneration.
Point Mutation
Point mutations identified in patients (e.g., KARS) can be introduced via CRISPR to model neuropathy and study structure-function relationships. These models help dissect catalytic versus non-canonical functions.
Knock-in
Tagged knock-in of subunits (e.g., GFP or HA tags) enables live-cell imaging and affinity purification of the complex. This approach is valuable for tracking assembly and localization.
Overexpression
CRISPR activation or cDNA overexpression of subunits like EPRS can model gain-of-function effects observed in cancer. Overexpression studies help identify oncogenic mechanisms.
How EDITGENE Supports aminoacyl-tRNA synthetase multienzyme complex Research
Researchers studying aminoacyl-tRNA synthetase multienzyme complex-related genes often need to determine whether a candidate gene is causally involved in disease or cellular processes. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for aminoacyl-tRNA synthetase multienzyme complex research.
Frequently Asked Questions About aminoacyl-tRNA synthetase multienzyme complex
What is the aminoacyl-tRNA synthetase multienzyme complex?
It is a large assembly of eight aminoacyl-tRNA synthetases and three auxiliary proteins that catalyzes tRNA aminoacylation.
What genes are involved in the aminoacyl-tRNA synthetase multienzyme complex?
Genes include RARS, DARS, EPRS, QARS, IARS, LARS, KARS, MARS, and AIMP1/2/3.
What is the function of GO:0017101?
It enables efficient covalent attachment of amino acids to tRNA for protein synthesis.
Which diseases are linked to the aminoacyl-tRNA synthetase multienzyme complex?
Cancer, Charcot-Marie-Tooth neuropathy, and infectious diseases.
How is the aminoacyl-tRNA synthetase multienzyme complex regulated?
Through protein-protein interactions, post-translational modifications, and mTOR signaling.
What is the difference between the multisynthetase complex and individual synthetases?
The complex enhances substrate channeling and efficiency compared to isolated enzymes.
Can CRISPR be used to study the aminoacyl-tRNA synthetase multienzyme complex?
Yes, knockout, point mutation, knock-in, and overexpression models are widely used.
What are the non-synthetase proteins in the complex?
p43 (AIMP1), p38 (AIMP2), and p18 (AIMP3).
Is the aminoacyl-tRNA synthetase multienzyme complex conserved?
Yes, it is ubiquitous from Drosophila to mammals.
What methods are used to study the complex?
AP-MS, Ribo-seq, RNA-seq, imaging, and aminoacylation assays.
Conclusion
The aminoacyl-tRNA synthetase multienzyme complex (GO:0017101) is a central hub for protein synthesis and a key player in human disease. Its intricate assembly and diverse functions make it a rich area for research. Leveraging CRISPR technologies, researchers can now dissect the roles of individual subunits and develop targeted therapies.
References
- 1. Freist W et al.. 1995. Lysyl-tRNA synthetase.. Biol Chem Hoppe Seyler 376(8):451-72 PMID: 7576245
- 2. Dang CV et al.. 1986. Multienzyme complex of aminoacyl-tRNA synthetases: an essence of being eukaryotic.. Biochem J 239(2):249-55 PMID: 3545179
- 3. Hyeon DY et al.. 2019. Evolution of the multi-tRNA synthetase complex and its role in cancer.. J Biol Chem 294(14):5340-5351 PMID: 30782841
- 4. Cestari I et al.. 2013. A multiple aminoacyl-tRNA synthetase complex that enhances tRNA-aminoacylation in African trypanosomes.. Mol Cell Biol 33(24):4872-88 PMID: 24126051
- 5. Kerjan P et al.. 1994. The multienzyme complex containing nine aminoacyl-tRNA synthetases is ubiquitous from Drosophila to mammals.. Biochim Biophys Acta 1199(3):293-7 PMID: 8161568
- 6. Cerini C et al.. 1991. A component of the multisynthetase complex is a multifunctional aminoacyl-tRNA synthetase.. EMBO J 10(13):4267-77 PMID: 1756734
- 7. Karanasios E et al.. 2007. Molecular determinants of the yeast Arc1p-aminoacyl-tRNA synthetase complex assembly.. J Mol Biol 374(4):1077-90 PMID: 17976650
- 8. Hausmann CD et al.. 2008. Aminoacyl-tRNA synthetase complexes: molecular multitasking revealed.. FEMS Microbiol Rev 32(4):705-21 PMID: 18522650
